A detailed history of State Street Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 5,800,790 shares of ACAD stock, worth $85.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,800,790
Previous 6,001,403 3.34%
Holding current value
$85.8 Million
Previous $111 Million 15.05%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$14.62 - $18.42 $2.93 Million - $3.7 Million
-200,613 Reduced 3.34%
5,800,790 $94.3 Million
Q1 2024

May 15, 2024

SELL
$17.79 - $30.86 $8.25 Million - $14.3 Million
-463,623 Reduced 7.17%
6,001,403 $111 Million
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $26 Million - $39.8 Million
1,251,295 Added 24.0%
6,465,026 $202 Million
Q3 2023

Nov 14, 2023

SELL
$20.84 - $33.47 $4.31 Million - $6.91 Million
-206,587 Reduced 3.81%
5,213,731 $109 Million
Q2 2023

Aug 14, 2023

SELL
$17.8 - $25.65 $2.96 Million - $4.27 Million
-166,543 Reduced 2.98%
5,420,318 $130 Million
Q1 2023

May 15, 2023

SELL
$16.32 - $20.92 $35.1 Million - $45.1 Million
-2,153,477 Reduced 27.82%
5,586,861 $105 Million
Q4 2022

Feb 14, 2023

BUY
$14.2 - $18.63 $13.7 Million - $17.9 Million
961,467 Added 14.18%
7,740,338 $123 Million
Q3 2022

Nov 15, 2022

BUY
$14.11 - $18.27 $2.61 Million - $3.38 Million
184,921 Added 2.8%
6,778,871 $111 Million
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $20 Million - $41.8 Million
1,536,756 Added 30.39%
6,593,950 $92.9 Million
Q1 2022

May 16, 2022

BUY
$20.94 - $27.5 $4.97 Million - $6.52 Million
237,241 Added 4.92%
5,057,194 $122 Million
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $15.3 Million - $24.6 Million
-908,370 Reduced 15.86%
4,819,953 $112 Million
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $27.7 Million - $43.5 Million
1,757,712 Added 44.27%
5,728,323 $95.1 Million
Q2 2021

Aug 16, 2021

BUY
$19.4 - $27.42 $14.8 Million - $20.9 Million
761,973 Added 23.75%
3,970,611 $96.8 Million
Q1 2021

May 17, 2021

BUY
$25.02 - $54.99 $15 Million - $32.9 Million
598,812 Added 22.94%
3,208,638 $82.8 Million
Q4 2020

Feb 16, 2021

SELL
$41.04 - $56.79 $3.81 Million - $5.27 Million
-92,758 Reduced 3.43%
2,609,826 $140 Million
Q3 2020

Nov 10, 2020

BUY
$36.42 - $57.0 $4.91 Million - $7.69 Million
134,840 Added 5.25%
2,702,584 $111 Million
Q2 2020

Aug 14, 2020

SELL
$39.26 - $52.73 $57.9 Million - $77.8 Million
-1,474,552 Reduced 36.48%
2,567,744 $124 Million
Q1 2020

May 11, 2020

BUY
$31.65 - $46.87 $128 Million - $189 Million
4,042,296 New
4,042,296 $171 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.